Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRB | AMGN | VRTX | BMY | GILD |
| Company | Spruce Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.3833 | 263.11 | 391.87 | 57.25 | 92.62 |
| High | 0.3948 | 264.80 | 405.93 | 57.66 | 93.52 |
| Low | 0.3650 | 260.87 | 390.92 | 56.80 | 91.79 |
| Last | 0.3775 | 264.00 | 405.27 | 57.58 | 93.40 |
| Change | -0.0225 | +0.62 | +8.00 | +0.25 | +0.83 |
| % Change | -5.63% | +0.24% | +2.01% | +0.44% | +0.90% |
| Volume | 770,500 | 3,025,700 | 2,204,400 | 9,431,900 | 4,809,500 |
| 20-Day Average Volume | 914,235 | 5,159,455 | 1,867,665 | 11,914,005 | 7,605,575 |
| Previous Close | 0.4000 | 263.38 | 397.27 | 57.33 | 92.57 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4673 | 273.49 | 454.68 | 57.92 | 92.13 |
| 20-Day Raw Stochastic | 5.98% | 24.31% | 27.81% | 45.04% | 77.27% |
| 20-Day Relative Strength | 36.07% | 32.92% | 32.75% | 53.40% | 56.96% |
| Weighted Alpha | -48.34 | -14.82 | -8.79 | +19.99 | +25.07 |
| Today's Opinion | 88% Sell | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 64% Sell | 40% Sell | 8% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.88% since 12/16/24 | -0.94% since 12/16/24 | -13.42% since 12/16/24 | +3.06% since 12/16/24 | +1.47% since 12/16/24 |
| Low | 0.3650 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 |
| High | 0.4180 on 12/17/24 | 270.26 on 12/17/24 | 474.18 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | -21.89% since 11/22/24 | -10.37% since 11/22/24 | -10.13% since 11/22/24 | -2.19% since 11/22/24 | +3.56% since 11/22/24 |
| Low | 0.3650 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 0.5740 on 11/29/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -11.38% since 09/23/24 | -21.34% since 09/23/24 | -11.90% since 09/23/24 | +15.14% since 09/23/24 | +11.20% since 09/23/24 |
| Low | 0.3650 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 |
| High | 0.6080 on 10/24/24 | 335.41 on 09/24/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -26.34% since 06/21/24 | -14.33% since 06/21/24 | -13.54% since 06/21/24 | +37.32% since 06/21/24 | +32.16% since 06/21/24 |
| Low | 0.3650 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 |
| High | 0.6080 on 10/24/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,521 | 141,575,456 | 102,308,544 | 116,275,392 | 115,366,840 |
| Shares Outstanding, K | 41,303 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 10,090,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -47,920,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 600,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -8,670,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.34 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/11/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/11/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 0.00 | 49.00 | 20.90 |